GlucoTab-guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes.
Felix AbererKatharina M LichteneggerEdin SmajicKlaus DonsaOliver MalleJudith SamoniggBernhard HöllPeter BeckThomas R PieberJohannes PlankJulia Katharina MaderPublished in: Diabetes, obesity & metabolism (2018)
Treatment with GlucoTab using insulin glargine U300 in hospitalized patients with T2D is effective and safe.